Literature DB >> 8613536

In vivo neutralization of eosinophil-derived major basic protein inhibits antigen-induced bronchial hyperreactivity in sensitized guinea pigs.

J Lefort1, M A Nahori, C Ruffie, B B Vargaftig, M Pretolani.   

Abstract

This study examines the effect of purified rabbit antiguinea pig eosinophil-derived major basic protein (MBP) Ig on antigen-induced bronchial hyperreactivity to inhaled acetylcholine in aerosol-sensitized guinea pigs. Ovalbumin inhalation by sensitized guinea pigs induced a rise in the numbers of eosinophils and in the levels of MBP in the bronchoalveolar lavage fluid, which peaked at 24 h and resolved at 72 h. Antigen-challenged animals exhibited bronchial hyperreactivity to inhale acetylcholine at 72 h, but not at 6 or 24 h. The intranasal administration of 200 microliter of purified rabbit anti-guinea pig MBP Ig, at 2.5 mg/ml, but not of the control preimmune rabbit Ig, 1 h before and 5 h after ovalbumin inhalation suppressed bronchial hyperreactivity to acetylcholine at 72 h without affecting the number of eosinophils accumulating in the bronchoalveolar lavage fluid. These findings indicate that antigen challenge in sensitized guinea pigs is followed by early eosinophil infiltration and activation within the airways and by late bronchial hyperreactivity. Neutralization of endogenously secreted MBP by a specific antiserum prevented antigen-induced bronchial hyperreactivity, suggesting that eosinophil degranulation plays an important role in the alterations of bronchopulmonary function in the guinea pig.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8613536      PMCID: PMC507160          DOI: 10.1172/JCI118505

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  29 in total

Review 1.  Epithelium-derived relaxing factor(s) and bronchial reactivity.

Authors:  P M Vanhoutte
Journal:  J Allergy Clin Immunol       Date:  1989-05       Impact factor: 10.793

2.  Local allergen challenge and bronchoalveolar lavage of allergic asthmatic lungs. Description of the model and local airway inflammation.

Authors:  W J Metzger; D Zavala; H B Richerson; P Moseley; P Iwamota; M Monick; K Sjoerdsma; G W Hunninghake
Journal:  Am Rev Respir Dis       Date:  1987-02

3.  Cytotoxic effects of the guinea pig eosinophil major basic protein on tracheal epithelium.

Authors:  E Frigas; D A Loegering; G J Gleich
Journal:  Lab Invest       Date:  1980-01       Impact factor: 5.662

4.  IL-3, IL-5, and granulocyte-macrophage colony-stimulating factor potentiate basophil mediator release stimulated by eosinophil granule major basic protein.

Authors:  E U Sarmiento; B R Espiritu; G J Gleich; L L Thomas
Journal:  J Immunol       Date:  1995-08-15       Impact factor: 5.422

5.  Identification by immunofluorescence of eosinophil granule major basic protein in lung tissues of patients with bronchial asthma.

Authors:  W V Filley; K E Holley; G M Kephart; G J Gleich
Journal:  Lancet       Date:  1982-07-03       Impact factor: 79.321

6.  Toxicity of eosinophil cationic proteins for guinea pig tracheal epithelium in vitro.

Authors:  S Motojima; E Frigas; D A Loegering; G J Gleich
Journal:  Am Rev Respir Dis       Date:  1989-03

7.  Damage of the airway epithelium and bronchial reactivity in patients with asthma.

Authors:  L A Laitinen; M Heino; A Laitinen; T Kava; T Haahtela
Journal:  Am Rev Respir Dis       Date:  1985-04

8.  Localization of eosinophil cationic protein, major basic protein, and eosinophil peroxidase in human eosinophils by immunoelectron microscopic technique.

Authors:  A Egesten; J Alumets; C von Mecklenburg; M Palmegren; I Olsson
Journal:  J Histochem Cytochem       Date:  1986-11       Impact factor: 2.479

9.  Identification of a major basic protein in guinea pig eosinophil granules.

Authors:  G J Gleich; D A Loegering; J E Maldonado
Journal:  J Exp Med       Date:  1973-06-01       Impact factor: 14.307

10.  Activation of basophil and mast cell histamine release by eosinophil granule major basic protein.

Authors:  M C O'Donnell; S J Ackerman; G J Gleich; L L Thomas
Journal:  J Exp Med       Date:  1983-06-01       Impact factor: 14.307

View more
  20 in total

Review 1.  Mammalian antibiotic peptides.

Authors:  P Síma; I Trebichavský; K Sigler
Journal:  Folia Microbiol (Praha)       Date:  2003       Impact factor: 2.099

Review 2.  Safety considerations in treating concomitant diseases in patients with asthma.

Authors:  L W Hunt
Journal:  Drug Saf       Date:  1998-05       Impact factor: 5.606

3.  The p110δ subunit of PI3K regulates bone marrow-derived eosinophil trafficking and airway eosinophilia in allergen-challenged mice.

Authors:  Bit Na Kang; Sung Gil Ha; Xiao Na Ge; M Reza Hosseinkhani; Nooshin S Bahaie; Yana Greenberg; Malcolm N Blumenthal; Kamal D Puri; Savita P Rao; P Sriramarao
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-03-16       Impact factor: 5.464

4.  Lung Pathologies in a Chronic Inflammation Mouse Model Are Independent of Eosinophil Degranulation.

Authors:  Elizabeth A Jacobsen; Sergei I Ochkur; Alfred D Doyle; William E LeSuer; Wen Li; Cheryl A Protheroe; Dana Colbert; Katie R Zellner; HuaHao H Shen; Charles G Irvin; James J Lee; Nancy A Lee
Journal:  Am J Respir Crit Care Med       Date:  2017-05-15       Impact factor: 21.405

5.  An essential role for interleukin-5 and eosinophils in helminth-induced airway hyperresponsiveness.

Authors:  L R Hall; R K Mehlotra; A W Higgins; M A Haxhiu; E Pearlman
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

Review 6.  Pulmonary neuronal M2 muscarinic receptor function in asthma and animal models of hyperreactivity.

Authors:  R W Costello; D B Jacoby; A D Fryer
Journal:  Thorax       Date:  1998-07       Impact factor: 9.139

7.  Interleukin-12 suppresses filaria-induced pulmonary eosinophilia, deposition of major basic protein and airway hyperresponsiveness.

Authors:  R K Mehlotra; L R Hall; A W Higgins; I A Dreshaj; M A Haxhiu; J W Kazura; E Pearlman
Journal:  Parasite Immunol       Date:  1998-10       Impact factor: 2.280

Review 8.  Ibuprofen and increased morbidity in children with asthma: fact or fiction?

Authors:  Ralph E Kauffman; Mary Lieh-Lai
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

9.  Distribution of major basic protein on human airway following in vitro eosinophil incubation.

Authors:  Ailing Xue; John Wang; Gary C Sieck; Mark E Wylam
Journal:  Mediators Inflamm       Date:  2010-03-22       Impact factor: 4.711

10.  Anti-inflammatory, immunomodulatory, and heme oxygenase-1 inhibitory activities of ravan napas, a formulation of uighur traditional medicine, in a rat model of allergic asthma.

Authors:  Sajida Abdureyim; Nurmuhammat Amat; Anwar Umar; Halmurat Upur; Benedicte Berke; Nicholas Moore
Journal:  Evid Based Complement Alternat Med       Date:  2010-10-05       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.